Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.56 SEK | -1.44% | 0.00% | -14.80% |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 53.35M | Sales 2025 * | 620M 57.07M | Capitalization | 371M 34.16M |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.58M | Net income 2025 * | 41M 3.77M | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 77.93M 7.17M | Net Debt 2025 * | 75.63M 6.96M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
12.9
x | P/E ratio 2025 * |
8.87
x | Employees | 228 |
Yield 2024 * |
2.14% | Yield 2025 * |
3.56% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | -1.44% | ||
Current month | -3.73% | ||
1 month | -1.95% | ||
3 months | -12.45% | ||
6 months | +1.70% | ||
Current year | -14.80% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Sales & Marketing | - | 21-09-30 | |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 15-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 9.56 | -1.44% | 1,521 |
24-04-23 | 9.7 | +0.83% | 2,928 |
24-04-22 | 9.62 | -2.43% | 14,206 |
24-04-19 | 9.86 | -0.20% | 3,085 |
24-04-18 | 9.88 | +3.35% | 11,066 |
Delayed Quote Nasdaq Stockholm, April 24, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.80% | 34.8M | |
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
+16.21% | 52.82B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B |
- Stock Market
- Equities
- BOUL Stock